Quantcast

Rockville-based Novavax falls short of expectations (access required)

Posted: 4:05 pm Fri, March 1, 2013
By Daily Record Staff

Novavax Inc., of Rockville, which is developing vaccines to treat viral infections, reported a fourth-quarter net loss of $8 million, or 6 cents per diluted share, versus a net loss of $3.7 million, or 3 cents per share, in the prior-year period.

Comments

Comments are closed.

Copyright © 2012, Maryland Daily Record 11 E. Saratoga Street, Baltimore, MD, 21202 · Tel: 443-524-8100